The Wall Street Journal reports that Boston Scientific said it likely won’t meet its financial guidance because a cyberattack has disrupted its operations. The warning sent the medical-technology company’s shares sharply lower in premarket trading, according to the Journal.
75.8K
2 posts, first seen 3d ago
Shares of the medical-technology company fell sharply in premarket trading after its warning, The Wall Street Journal reports.
The Wall Street Journal reports that Boston Scientific said it likely won’t meet its financial guidance because a cyberattack has disrupted its operations. The warning sent the medical-technology company’s shares sharply lower in premarket trading, according to the Journal.
Not enough discussion yet.
No sentiment analysis available yet.
Not enough discussion yet.
No sentiment analysis available yet.
—
Not ranked yet
—
Not ranked yet